Kazuki Nozawa, Yukinori Ozaki, Tomohiro Oshino, Kaori Terata, Chikako Funasaka, Hitomi Sakai, Manabu Futamura, Chiyoe Kitagawa, Tsutomu Iwasa, Tatsuya Toyama, Mikiya Ishihara, Shinichiro Kashiwagi, Koji Matsumoto, Yuko Takahashi, Satomi Watanabe, Hideo Shigematsu, Toshimi Takano. "A randomized phase II study of pembrolizumab plus paclitaxel with or without bevacizumab in PD-L1–positive recurrent triple-negative breast cancer previously treated with perioperative immune checkpoint inhibitors: WJOG16522B (PRELUDE) trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps1163